[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  M [@bio_clouseau](/creator/twitter/bio_clouseau) on x 19.6K followers Created: 2025-07-19 09:53:22 UTC $SRPT gets a platform tech designation on 6/4 for its AAVrh74 viral vector for LGMD 2E/R4 which seems to indicate the viral vector is "well understood" and "utilized by more than one drug without an adverse effect on quality, manufacturing, or safety". A little more than a month later FDA asks to voluntarily stop all shipments and issues a statement saying Sarepta "refused" the request and also pulls the platform designation just handed a month earlier. A lot of fingers being pointed at SRPT (rightfully)for being far from transparant but the FDA is not without fault either with its new found eagerness to hand out designations for social media points, seem industry friendly and then pull the rug from underneath industry when public social media outrage builds. This is an FDA driven by X and FB and every other real time social media out there. Not for the faint of heart investor or even families who may have relied on the platform designation as a sign that the drug was safe  XXXXXX engagements  **Related Topics** [$srpt](/topic/$srpt) [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/bio_clouseau/status/1946508655873995232)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
M @bio_clouseau on x 19.6K followers
Created: 2025-07-19 09:53:22 UTC
$SRPT gets a platform tech designation on 6/4 for its AAVrh74 viral vector for LGMD 2E/R4 which seems to indicate the viral vector is "well understood" and "utilized by more than one drug without an adverse effect on quality, manufacturing, or safety". A little more than a month later FDA asks to voluntarily stop all shipments and issues a statement saying Sarepta "refused" the request and also pulls the platform designation just handed a month earlier. A lot of fingers being pointed at SRPT (rightfully)for being far from transparant but the FDA is not without fault either with its new found eagerness to hand out designations for social media points, seem industry friendly and then pull the rug from underneath industry when public social media outrage builds. This is an FDA driven by X and FB and every other real time social media out there. Not for the faint of heart investor or even families who may have relied on the platform designation as a sign that the drug was safe
XXXXXX engagements
Related Topics $srpt sarepta therapeutics inc stocks healthcare